Efficacy and Safety Study of HU00701/HU007 Eye Drops in Patients With Dry Eye Syndrome

PHASE2CompletedINTERVENTIONAL

Enrollment

114

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions

Dry Eye Syndrome

Interventions

DRUG

HU00701

Cyclosporine 0.01% + 3% trehalose

DRUG

HU007

Cyclosporine 0.02% + 3% trehalose

DRUG

Restasis

Cyclosporine 0.05%

DRUG

Placebo

Vehicle

Trial Locations (1)

Huons, Seongnam-si

All Listed Sponsors

lead

Huons Co., Ltd.

INDUSTRY

NCT02917512 - Efficacy and Safety Study of HU00701/HU007 Eye Drops in Patients With Dry Eye Syndrome | Biotech Hunter | Biotech Hunter